Streetbeat News

Products Services

ALKS

Alkermes plans to present clinical data from its Phase 1B study of ALKS 2680, targeting narcolepsy type 2 and idiopathic hypersomnia, at the European Sleep Research Society Congress in 2024.

Portfolio Pulse from Benzinga Newsdesk

September 23, 2024 | 11:02 am

BDTX

Black Diamond Therapeutics reported promising Phase 2 results for BDTX-1535 in treating EGFR-mutant non-small cell lung cancer, showing a 42% response rate and good tolerability. The company aims for FDA approval and plans to release more data in 2025.

Portfolio Pulse from Benzinga Newsdesk

September 23, 2024 | 11:01 am

ACM

AECOM has been selected by the City of Austin to lead the expansion of the Walnut Creek Wastewater Treatment Plant, increasing its capacity from 75 MGD to 100 MGD. This project aims to modernize the plant's infrastructure and improve environmental features, supporting Austin's growing population.

Portfolio Pulse from Benzinga Newsdesk

September 23, 2024 | 10:59 am

AZN

AstraZeneca's Fasenra has been recommended for approval in the EU as an add-on treatment for adult patients with relapsing or refractory eosinophilic granulomatosis with polyangiitis. The recommendation is based on the MANDARA Phase III trial results.

Portfolio Pulse from Benzinga Newsdesk

September 23, 2024 | 10:49 am

ABAT

American Battery Technology Company (NASDAQ:ABAT) has secured a $150 million grant from the U.S. Department of Energy to construct a second lithium-ion battery recycling facility. This facility will process 100,000 tonnes of battery materials annually and is part of ABTC's strategy to expand its domestic battery recycling operations. The project involves multiple partners and aims to create significant job opportunities while supporting sustainable initiatives.

Portfolio Pulse from Benzinga Newsdesk

September 23, 2024 | 10:47 am

IREN

Iris Energy Limited (NASDAQ:IREN) has increased its capacity to 20 EH/s and plans to reach 31 EH/s by the end of 2024. The company is optimizing its data center infrastructure and expanding its operations with new Bitmain S21 XP miners.

Portfolio Pulse from Benzinga Newsdesk

September 23, 2024 | 10:37 am

SGN

Signing Day Sports plans to acquire Swifty Global, expecting strategic and financial synergies to drive growth and efficiency. The acquisition aims to reduce costs, enhance SaaS revenue, expand market exposure, and improve user engagement.

Portfolio Pulse from Benzinga Newsdesk

September 23, 2024 | 10:35 am

XOMA

ZVRA

XOMA Royalty announced that Zevra Therapeutics has received FDA approval for MIPLYFFA. XOMA is entitled to receive mid-single digit royalties on MIPLYFFA sales and up to $52.6 million in milestone payments.

Portfolio Pulse from Benzinga Newsdesk

September 23, 2024 | 10:34 am

ARKB

BITB

BITO

FBTC

GBTC

Bitcoin reached a new high of $63,500, leading to a surge in pre-market activity for several Bitcoin ETFs. Grayscale Bitcoin Trust, Bitwise Bitcoin ETF, and ProShares Bitcoin Strategy ETF saw notable increases. The surge is attributed to a favorable macroeconomic backdrop and potential end of Bitcoin's correction phase.

Portfolio Pulse from Benzinga Neuro

September 23, 2024 | 10:30 am

MVPA

OCTA

TTE

TotalEnergies has signed a significant deal with Air France-KLM to supply 1.5 million tons of sustainable aviation fuel over the next decade, reinforcing their commitment to reducing CO2 emissions. TotalEnergies is also investing in biorefinery conversion and renewable energy projects.

Portfolio Pulse from Lekha Gupta

September 23, 2024 | 10:21 am